The Patent Finder

Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer

Corcept Therapeutics Incorporated

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 8 of these applications claim priority to application 62/385,590, filed Sep 9, 2016. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,943,505Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
UsedRemaining
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,117,852Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,213,414Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,449,178Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,646,474Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 10,828,280Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 11,642,331Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
US 12,370,175Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
In force
 · High confidence
Corcept Therapeutics, Inc.In forceHigh confidence
Application 19/242,707Glucocorticoid Receptor Modulators to Treat Pancreatic Cancer
Pending
Not granted
Corcept Therapeutics, Inc.PendingNot granted
9 of 9 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by Corcept Therapeutics Incorporated.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited